Phoenix bioscience boom poised to improve health care and local economy, proponents say / Arizona Republic
The bioscience industry is booming in Phoenix, and industry leaders say it means better health care, a stronger economy and innovation that could one day cure cancer.
GT Medical Technologies to expand brain tumor therapy with $35 million venture loan / Phoenix Business Journal (AZ Inno)
GT Medical Technologies of Tempe has obtained a $35 million venture loan facility to fund expansion of GammaTile, its FDA-cleared targeted radiation therapy in the form of a small tile that brain surgeons can place in an incision site after removing a brain tumor.
New UA study suggests RNA plays a big role in reproductive process / KJZZ
A University of Arizona study about RNA could provide insight into potential new modes to increase fertilization success in agricultural animals or solve problems of infertility in humans.
University of Arizona professor receives national award for breakthrough technology / KOLD
University of Arizona professor Hong Hua, who has collaborated with Tech Launch Arizona, received a national award for developing electronic glasses that help the legally blind see.
Behind the deal: How HonorHealth added multiple Arizona hospitals in one swift move / Phoenix Business Journal
Todd LaPorte, CEO of Scottsdale-based HonorHealth, has been expanding the nonprofit health system outside Scottsdale over the past several years, including southeast towards Pinal County. But he didn’t envision a broad expansion would happen so quickly.
Here’s how AZBio is championing health innovation / AZ Big Media (Op-ed)
During this Arizona Bioscience Week, Joan Koerber-Walker, president and CEO of the Arizona Bioindustry Association, writes about Arizona innovators improving the lives of people in the state, across the country, and around the world.
Upcoming Events:
September 20: Voice of the Patient
September 26: Flinn seed grants application deadline
September 28: Yuma Research Transforming Communities Symposium
October 16: Addressing Challenges with FDA 483s and Warning Letters in Clinical Trials
December 11: reimagine Health Research Symposium